Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Sarcoma 10Sarcoma, Ewing 4Liposarcoma 4Rhabdomyosarcoma 3Rhabdoid Tumor 3Osteosarcoma 3Neuroblastoma 3Medulloblastoma 3Glioma 3Wilms Tumor 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Chordoma 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Urinary Bladder Neoplasms 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Liposarcoma, Myxoid 1Histiocytic Sarcoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 39Peripheral Blood Stem Cell Transplantation 32fludarabine phosphate 30Busulfan 26Filgrastim 24Cyclosporine 24Mycophenolic Acid 22Antilymphocyte Serum 22Radiotherapy 20Melphalan 16Whole-Body Irradiation 15Tacrolimus 14Methylprednisolone 14Methotrexate 13Cord Blood Stem Cell Transplantation 12Etoposide 10sargramostim 5Thiotepa 5Temozolomide 5Sirolimus 5Rituximab 5Bevacizumab 5aldesleukin 4Therapeutics 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4Carmustine 4pembrolizumab 3Vincristine 3Topotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × palbociclib × Sarcoma × Clear all
NCT04129151 2024-08-01

Palbociclib + Ganitumab In Ewing Sarcoma

Dana-Farber Cancer Institute

Phase 2 Terminated
10 enrolled 15 charts
Sarcoma

Recurrence, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡